Brochure
26 Apr 2025
CDMO
JPG 113 kB
Content provided by our supplier
GENOVIOR BIOTECH CORPORATION
-
Country/Region:Taiwan
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
Other Content from GENOVIOR BIOTECH CORPORATION (2)
-
Report Genovior company overview presentation
Company General Overview Introduction -
Brochure COMPANY PRESENTATION
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production
6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs
Generic/Peptide/Biosimilar projects available for out-licensing
Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
Biosimilar-Liraglutide, Ranibizumab, Denosumab
Others-Levetiracetam, Palonosetron, Valproate